Stepan Company (SCL) Q4 2025 earnings summary

Executive summary

• 2025 marked a transformational year with record safety performance, divestitures, asset optimization, and the launch of Project Catalyst targeting $100 million in pre-tax savings over two years through footprint optimization and operational efficiency.

• Adjusted EBITDA grew 6% to $198.9 million for the year, driven by disciplined pricing, cost management, and favorable mix, despite a challenging macro environment.

• Organic volume increased 2% year-over-year, led by crop productivity, oil field, Tier 2/3 customers, Polymers, and Specialty Products, with strong strategic segment growth and successful commissioning of the Pasadena, TX facility.

• Positive free cash flow and improved net leverage ratio from 2.8x to 2.5x year-over-year, supported by working capital management.

• Announced closure of Fieldsboro, NJ, and decommissioning of select assets at Millsdale and Stalybridge as part of Project Catalyst.

Financial highlights

• Full year reported net income was $46.9 million, down 7% year-over-year; adjusted net income was $41.7 million, down 17%.

• Full year EBITDA increased 11% to $208 million; adjusted EBITDA up 6% to $198.9 million.

• Q4 2025 adjusted net loss was $0.5 million; reported net income was $5 million, up 49% year-over-year due to asset sale gains and non-recurring items.

• Q4 adjusted EBITDA was $33.8 million, down 3% year-over-year, mainly from lower surfactants income and higher raw material costs.

• Free cash flow for Q4 was $25.4 million, up from negative $0.2 million prior year, driven by reduced working capital.

Outlook and guidance

• Expect adjusted EBITDA growth and positive free cash flow in 2026, with H2 performance stronger than H1 due to margin recovery and Project Catalyst savings.

• Project Catalyst expected to deliver $100 million in pre-tax savings over two years, with about 60% realized in 2026; inflation will offset some savings.

• CapEx guidance for 2026 is $105–$115 million, with effective tax rate expected to rise to 25–27% due to new US tax legislation.

• Q1 2026 impacted by historic weather, with $6 million EBITDA loss, mostly in surfactants; at least half expected to be recovered in later quarters.

• Anticipate demand recovery in H2 2026, supported by projected interest rate cuts and improved raw material costs.